Lemtrada and Campath Lawsuit
If you or a loved one has taken Lemtrada or Campath, also known as alemtuzumab, and experienced complications like stroke or arterial tears, you may be entitled to compensation. The Birmingham personal injury lawyer team at Pittman, Dutton, Hellums, Bradley & Mann works nationwide with victims of defective pharmaceuticals. We are currently accepting clients from around the country who are victims of negligence on behalf of Lemtrada, Campath and other pharmaceutical companies.
As of November 2018, the U.S. Food & Drug Administration (FDA) had identified 13 cases around the world of ischemic and hemorrhagic stroke or arterial dissection shortly after patients received Lemtrada. This number may be far smaller than the amount of people suffering, because it only reflects the number of cases that have been reported to the FDA.
Complications stemming from Lemtrada and Campath may lead to permanent disability or death. Do not delay in calling our team today, toll-free at (205) 322-8880. The statute of limitations places a limit on the time frame in which a victim may pursue legal action. Contact us for a free, no-obligation pharmaceutical lawyer consultation to see how we can help you obtain justice for yourself or a loved one.
Latest Known Facts:
- In 2018, the FDA added the risk of stroke to the existing Boxed Warnings of Lemtrada and Campath
- This “black box warning” is the most prominent warning the FDA gives and is only issued when there is risk of serious health issues due to taking the drug
- Any future drug containing alemtuzumab will be required to have a Boxed Warning on it for risk of stroke and arterial tearing
- In most cases of stroke or tears in artery linings after taking Lemtrada, patients experienced symptoms within one day, while one patient reported symptoms three days after taking Lemtrada
- With the FDA’s recent announcement, more cases may be reported and added to the list of victims
The National Stroke Association calls a stroke a “brain attack.” While a stroke is happening, blood flow to an area of the brain is cut off, which means brain cells are deprived of oxygen and begin to die.
When those brain cells die, abilities like muscle control or memory loss may be impaired or lost. More than two-thirds of stroke survivors will have some type of disability after the stroke.
The types of strokes associated with Lemtrada are ischemic and hemorrhagic stroke. Ischemic stroke is when a blood vessel carrying blood to the brain is blocked by a blood clot. Hemorrhagic strokes are deadlier and occur when a brain aneurysm bursts or a blood vessel leaks. Blood spills into or around the brain, creating swelling and pressure.
Warning signs of stroke and what to do can be remembered using the acronym FAST. This stands for:
Face: Drooping occurs.
Arms: If someone cannot lift both arms equal levels, a stroke may be occurring.
Speech: Talking may become strange or slurred.
Time: If any of these signs appear, emergency services should be immediately contacted.
Other symptoms of stroke include:
Sudden numbness or weakness, especially on one side of the body
Sudden confusion, understanding or difficulty speaking
Sudden trouble seeing in one or both eyes
Sudden trouble walking, dizziness or loss of balance or coordination
Sudden severe headache
Arterial dissection has warning signs that are similar to stroke, and it is the leading cause of stroke in young people. A tear in the artery limits the flow of blood or may close it off entirely. Warning signs of arterial dissection include:
Sudden difficulty speaking
Sudden partial or complete blindness
Severe headaches and head and neck pain
If you know someone on Lemtrada or Campath and they experience any of these signs, call an ambulance immediately. Be especially vigilant during the first three days after receiving either of these treatments, and watch for warning signs.
The medications you and your loved one take should help you, not harm you. Unfortunately, this is not always the case. Big pharmaceutical companies may push drugs to market with flaws or improper testing. The result can be as serious as death.
If you or a loved one is a victim of pharmaceutical negligence, contact the Pittman, Dutton, Hellums, Bradley & Mann pharmaceutical litigation team. Our consultations are completely free and no-obligation. We only take on cases we believe we can win. You only pay if we are successful.
Our team has decades of experiencing fighting big pharmaceutical companies that take advantage of patients. Call (205) 322-8880, or contact us online for a free Campath and Lemtrada lawsuit consultation.
Get a Free Case Evaluation
Fill out the form below to contact our firm. One of our experienced attorneys is prepared to speak with you. Consultations are free and confidential.